Cas no 7471-26-3 (N-(4-Methoxyphenyl)benzenesulfonamide)
N-(4-Methoxyphenyl)benzenesulfonamide Chemical and Physical Properties
Names and Identifiers
-
- Benzenesulfon-p-anisidide
- AC1LB9Q2
- ARONIS001569
- Benzamide, N-(4-methoxyphenyl)-4-fluoro-
- benzenesulfonic acid p-anisidide
- Benzolsulfonsaeure-p-anisidid
- JUEQLTHFAHLSAQ-UHFFFAOYSA-
- N-(4-methoxyphenyl)-4-fluorobenzamide
- N-(p-anisyl)-4-fluorobenzamide
- N-4'-methoxyphenyl-4-fluorobenzamide
- N-4-methoxyphenylbenzenesulfonamide
- Oprea1_428271
- Oprea1_821987
- ST039896
- SureCN6295993
- N-(4-Methoxyphenyl)benzenesulfonamide
- Oprea1_332995
- Oprea1_282218
- 4'-Methoxybenzenesulfonanilide
- IFLab1_003758
- UZUQLWPXATZCDY-UHFFFAOYSA-N
- HMS1422K18
- STK899552
- NSC403569
- (4-methoxyphenyl)(phenylsulfonyl)amine
- N-(4-methoxy-phenyl)benzenesulfonamide
- IDI1_009865
- N-(4-Methoxyphenyl)benzenesulfonamide #
- Benzensulfonamide, N-(4-methoxyphenyl)-
- 7471-26-3
- CS-12743
- BB 0258912
- AKOS001064750
- SR-01000416254-1
- SCHEMBL4662975
- NSC-403569
- F0808-1402
- DTXSID90902044
- MFCD00586058
- Z45633893
- SY224204
- N-(4-METHOXY-PHENYL)-BENZENESULFONAMIDE
- 6947-34-8
- EN300-16003
- A915548
- SR-01000416254
- AC2483
- CS-0109285
- NoName_1247
- DB-130286
- AE-641/00009018
- Benzenesulfonamide, N-(4-methoxyphenyl)-
-
- MDL： MFCD00586058
- Inchi： 1S/C13H13NO3S/c1-17-12-9-7-11(8-10-12)14-18(15,16)13-5-3-2-4-6-13/h2-10,14H,1H3
- InChI Key： UZUQLWPXATZCDY-UHFFFAOYSA-N
- SMILES： S(C1C=CC=CC=1)(NC1C=CC(=CC=1)OC)(=O)=O
Computed Properties
- Exact Mass: 263.06169
- Monoisotopic Mass: 263.062
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 18
- Rotatable Bond Count: 4
- Complexity: 336
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.2
- Topological Polar Surface Area: 63.8
Experimental Properties
- Density: 1.3±0.1 g/cm3
- Melting Point: Not available
- Boiling Point: 417.8±47.0 °C at 760 mmHg
- Flash Point: 206.5±29.3 °C
- PSA: 55.4
- LogP: 3.64980
- Vapor Pressure: 0.0±1.0 mmHg at 25°C
N-(4-Methoxyphenyl)benzenesulfonamide Security Information
- Signal Word：warning
- Hazard Statement： H303+H313+H333
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Safety Instruction： H303+H313+H333
- Storage Condition：storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
N-(4-Methoxyphenyl)benzenesulfonamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y13635-5g |
N-(4-Methoxyphenyl)benzenesulfonamide |
7471-26-3 | 97% | 5g |
￥2859.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y13635-1g |
N-(4-Methoxyphenyl)benzenesulfonamide |
7471-26-3 | 97% | 1g |
￥1029.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y13635-10g |
N-(4-Methoxyphenyl)benzenesulfonamide |
7471-26-3 | 97% | 10g |
￥4729.0 | 2023-09-05 | |
| abcr | AB392427-250 mg |
N-(4-Methoxyphenyl)benzenesulfonamide, 97%; . |
7471-26-3 | 97% | 250mg |
€109.40 | 2023-04-25 | |
| abcr | AB392427-1 g |
N-(4-Methoxyphenyl)benzenesulfonamide, 97%; . |
7471-26-3 | 97% | 1g |
€181.80 | 2023-04-25 | |
| abcr | AB392427-5 g |
N-(4-Methoxyphenyl)benzenesulfonamide, 97%; . |
7471-26-3 | 97% | 5g |
€415.30 | 2023-04-25 | |
| abcr | AB392427-10 g |
N-(4-Methoxyphenyl)benzenesulfonamide, 97%; . |
7471-26-3 | 97% | 10g |
€656.80 | 2023-04-25 | |
| abcr | AB392427-25 g |
N-(4-Methoxyphenyl)benzenesulfonamide, 97%; . |
7471-26-3 | 97% | 25g |
€1260.50 | 2023-04-25 | |
| eNovation Chemicals LLC | D685784-1g |
N-(4-Methoxyphenyl)benzenesulfonamide |
7471-26-3 | 97% | 1g |
$105 | 2024-07-20 | |
| A2B Chem LLC | AH20259-250mg |
N-(4-Methoxyphenyl)benzenesulfonamide |
7471-26-3 | 97% | 250mg |
$90.00 | 2024-04-19 |
N-(4-Methoxyphenyl)benzenesulfonamide Suppliers
Audited Supplier
N-(4-Methoxyphenyl)benzenesulfonamide Related Literature
-
M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
Additional information on N-(4-Methoxyphenyl)benzenesulfonamide
Professional Introduction to N-(4-Methoxyphenyl)benzenesulfonamide (CAS No. 7471-26-3)
N-(4-Methoxyphenyl)benzenesulfonamide, a compound with the chemical identifier CAS No. 7471-26-3, represents a significant area of interest in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its 4-methoxyphenyl and benzenesulfonamide functional groups, has garnered attention due to its potential applications in drug discovery and development. The structural features of this molecule contribute to its unique chemical properties, making it a valuable candidate for further exploration in synthetic chemistry and biological assays.
The benzenesulfonamide moiety is particularly noteworthy, as sulfonamides are well-documented for their role in various therapeutic contexts. They exhibit a broad spectrum of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The presence of the 4-methoxyphenyl group introduces additional complexity to the molecule, influencing its solubility, stability, and interaction with biological targets. This combination of structural elements makes N-(4-Methoxyphenyl)benzenesulfonamide a promising candidate for further investigation.
In recent years, there has been a surge in research focused on developing novel sulfonamide derivatives as pharmacological agents. The< strong>N-(4-Methoxyphenyl)benzenesulfonamide structure has been explored for its potential to modulate various biological pathways. For instance, studies have indicated that sulfonamides can interact with enzymes and receptors in ways that may lead to therapeutic benefits. The methoxy group on the phenyl ring further enhances these interactions by influencing electronic properties and steric hindrance.
The pharmaceutical industry has shown particular interest in derivatives of benzenesulfonamides due to their favorable pharmacokinetic profiles. N-(4-Methoxyphenyl)benzenesulfonamide, with its specific substitution pattern, has been investigated for its ability to cross the blood-brain barrier and reach central nervous system targets. This property is crucial for developing treatments for neurological disorders such as Alzheimer's disease and Parkinson's disease, where central nervous system penetration is essential.
Moreover, the< strong>CAS No. 7471-26-3 compound has been the subject of several synthetic studies aimed at optimizing its structure for enhanced biological activity. Researchers have employed various strategies, including computational chemistry and high-throughput screening, to identify modifications that could improve efficacy while minimizing side effects. These efforts have led to the discovery of several analogs with improved pharmacological profiles.
The< strong>4-methoxyphenyl group in N-(4-Methoxyphenyl)benzenesulfonamide plays a critical role in determining its overall behavior as a pharmacological agent. This substituent can influence both the electronic distribution within the molecule and its interactions with biological targets. By modulating the position and nature of this group, chemists can fine-tune the compound's properties to achieve desired therapeutic effects.
In addition to its pharmaceutical applications, N-(4-Methoxyphenyl)benzenesulfonamide has potential uses in materials science and industrial chemistry. Its unique structural features make it a candidate for developing new materials with specialized properties, such as enhanced thermal stability or improved electronic conductivity. These applications are still under exploration but hold promise for future advancements.
The synthesis of< strong>N-(4-Methoxyphenyl)benzenesulfonamide involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic techniques have been employed to achieve high yields and purity levels necessary for pharmaceutical use. These methods often involve catalytic processes and protective group strategies to ensure optimal reaction outcomes.
Ongoing research continues to uncover new aspects of N-(4-Methoxyphenyl)benzenesulfonamide's behavior and potential applications. Collaborative efforts between academic institutions and pharmaceutical companies are driving innovation in this field, leading to exciting discoveries that could impact human health in significant ways.
In conclusion, N-(4-Methoxyphenyl)benzenesulfonamide (CAS No. 7471-26-3) is a versatile compound with considerable potential in pharmaceuticals and beyond. Its unique structural features make it an attractive candidate for further study, with applications ranging from drug development to advanced materials science. As research progresses, we can expect to see more insights into its properties and functionalities, paving the way for new therapeutic interventions and technological advancements.
7471-26-3 (N-(4-Methoxyphenyl)benzenesulfonamide) Related Products
- 62035-67-0(Benzenesulfonamide, N-(3,4-dimethoxyphenyl)-)
- 106003-96-7(Benzenesulfonamide, 4,4'-oxybis[N-[4-[(methylsulfonyl)amino]phenyl]-)
- 19837-79-7(4-Amino-N-(3-methoxyphenyl)benzenesulfonamide)
- 106149-18-2(N-(4-phenoxyphenyl)benzenesulfonamide)
- 201996-24-9(3-AMINO-N-(4-METHOXY-PHENYL)-BENZENESULFONAMIDE)
- 22865-27-6(Benzenesulfonamide,N-(3-methoxyphenyl)-)
- 19837-74-2(4-amino-N-(4-methoxyphenyl)benzene-1-sulfonamide)
- 1146-41-4(Benzenesulfonamide, 4-methoxy-N-phenyl-)
- 24924-59-2(4-Methoxy-N-(4-Methoxyphenyl)Benzenesulfonamide)
- 6947-34-8(N-(4-methoxyphenyl)benzenesulfonamide)
